Oncorus

Oncorus Inventory Turnover

Delisted

Inventory Turnover Ratio of Oncorus (ONCR) as of Oct 18, 2026.

Inventory Turnover

-

Last updated:

Inventory Turnover Ratio of Oncorus is 2026 - . Inventory Turnover Ratio of Oncorus was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncorus Stock analysis

What does Oncorus do? Oncorus Inc, based in Andover, Massachusetts, develops viral immunotherapies for cancer treatment. The company focuses on a self-amplifying RNA platform, with product candidates ONCR-021 for non-small cell lung cancer and other solid tumors, and ONCR-788 targeting Seneca Valley Virus. Oncorus employs 64 full-time staff and went public on 2 October 2020. Its research aims to enhance anti-tumor immunity through viral-based therapies. Oncorus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncorus stock

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio Oncorus since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's Oncorus with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Oncorus

All Key Metrics — Oncorus